A Health-Related Quality of Life Measure for Patients Who Undergo Minimally Invasive Glaucoma Surgery.

ABSTRACT:

Purpose

To develop a patient-reported outcome measure to assess the impact of glaucoma and treatment, including minimally invasive glaucoma surgery (MIGS).

Design

Observational study before and after concomitant cataract and Food and Drug Administration-approved implantable MIGS device surgery.

Setting

Survey administration was on a computer, iPad, or similar device.

Patient population

184 adults completed the baseline survey, 124 a survey 3 months after surgery, and 106 the 1-month test-retest reliability survey. The age range was 37 to 89 (average age = 72). Most were female (57%), non-Hispanic White (81%), and had a college degree (56%).

Main outcome measures

The Glaucoma Outcomes Survey (GOS) assesses functional limitations (27 items), vision-related

SUBMITTER: Hays RD 

PROVIDER: S-EPMC11956037 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature